1. Main page
  2. Biotechnology
  3. Neovacs

Neovacs

4 Decision Makers · 4 Verified Contacts

neovacs.fr
📍 Paris, Ile-de-France, FranceBiotechnology🗓 Est. 1993👥 11–50 employees

About Neovacs

Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.

Leadership & Decision Makers

Contact details of 4 Neovacs decision makers

Miguel Sieler

Chief Executive Officer

Vincent Serra

Chief Scientific Officer

Daniel Zagury

Founder

Charlène Masson

Corporate Communication Director

General Emails

General company emails, e.g. customer support lines

    contact@neovacs.com

    General Inquiries

    info@neovacs.fr

    General Inquiries

    bernardfanget@neovacs.fr

    Unclassified inbox

    geraldinevogel@neovacs.fr

    Unclassified inbox

Verify Neovacs Emails

Similar Companies like Neovacs

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees

HQ: Cambridge, MA

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 31/07/2025

neovacs.fr

33 1 53 10 93 00

Paris, Ile-de-France, France

Specialization: Therapeutics,
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Debt
Founded Date: 1993
Number of Exits: 1
Company Type: For Profit
Stock Symbol: EPA:ALNEV
Operating Status: Active
Last Funding Type: Post-IPO Debt
Phone Number: 33 1 53 10 93 00
Last Investment Activity: Jun 17, 2024
Investments Activity: Jun 17, 2024 May 27, 2024 Jan 17, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.